The Trump administration’s actions on NIH gain-of-function research have raised concerns among scientists, who argue the move could block experiments that are safe and potentially lead to new treatments and medicines.
View original article
Contributor: Hannah Natanson, Carolyn Y. Johnson, Joel Achenbach